Statistics on Biotechnology Use Results by sector of operation Company sector. Biotechnology results by main variables by whichever Biotechnology activities are the main ones, secondary or a tool necessary for production Unidades: specified in variables Total Main Secondary dwellings Tool Companies that carry out R&D in Biotechnology 1.133 564 212 358 %Companies according to biotechnology used: Genetic code 32 42 22 20 %Companies according to biotechnology used: Functional units 41 48 40 30 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 27 33 24 19 %Companies according to biotechnology used: Bioprocesses 48 41 47 60 %Companies according to biotechnology used: Sub-cellular organisms 8 11 8 4 %Companies according to biotechnology used: Bio-computing 21 31 13 11 %Companies according to biotechnology used: Nanobiotechnology 14 18 16 7 %Companies according to biotechnology used: Other 13 13 15 12 %Company by field(s) of ultimate application of biotechnology use: Human Health 50 70 42 23 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 19 21 18 17 %Company by field(s) of ultimate application of biotechnology use: Food products 29 22 30 40 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 21 19 25 23 %Company by field(s) of ultimate application of biotechnology use: Environment 13 11 20 10 %Company by field(s) of ultimate application of biotechnology use: Industry 13 13 18 12 Personnel in R&D in biotechnology (no. of persons) 10.706 5.968 1.806 2.932 Personnel in R&D in biotechnology (no. of persons): Researchers 6.227 3.765 994 1.467 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 4.479 2.202 812 1.464 Personnel in R&D in biotechnology (no. of persons): women 5.795 3.402 884 1.510 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 3.269 2.049 503 717 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 2.527 1.353 381 793 Personnel in R&D in biotechnology (FTE) 7.716,4 4.708,3 1.165,8 1.842,3 Personnel in R&D in biotechnology (FTE): Researchers 4.603,1 2.952,5 690,5 960,1 Personnel in R&D in biotechnology (FTE): Technicians and assistants 3.113,3 1.755,8 475,3 882,2 Personnel in R&D in biotechnology (FTE): women 4.292,9 2.666 584,9 1.042 Personnel in R&D in biotechnology (FTE): (women) Researchers 2.446,4 1.592,2 352,1 502,1 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 1.846,5 1.073,7 232,8 539,9 Internal expenditure on R&D (thousands of euros) 616.053 401.754 86.676 127.622 1) By nature of the expense: Current expenses 574.245 371.873 81.601 120.772 1.1) Remuneration to researchers 221.741 145.148 33.906 42.688 1.2) Remuneration to technicians and assistants 102.464 53.306 17.155 32.002 1.3) Other current expenses 250.041 173.419 30.540 46.082 2) By nature of the expense: Capital expenses 41.808 29.882 5.075 6.851 2.1) Land and buildings 5.359 3.592 486 1.281 2.2) Equipment and instruments 29.489 20.787 4.073 4.630 2.3) Acquisition of specific R+D software 2.306 1.549 139 618 2.4) Otros productos de propiedad intelectual específicos para I+D 4.654 3.955 377 322 1) By origin of the funds: National funds 511.960 311.167 76.048 124.744 1.1) Own funds 382.335 232.410 47.954 101.970 1.2) From companies 45.024 25.073 10.783 9.168 1.3) Public Administration funds 72.387 45.317 16.642 10.428 1.4) From Universities 363 363 0 . 1.5) From non profit private institutions 11.851 8.005 669 3.178 1) By origin of the funds: Foreign funds 104.093 90.587 10.628 2.879 2.1) From EU programmes 21.825 13.669 5.814 2.342 2.2) Other foreign funds 82.269 76.918 4.813 537 Purchase of R&D services in biotechnology (thousands of euros) 144.342 91.533 26.448 26.360 Purchase of R&D services in biotechnology (thousands of euros): In Spain 70.458 43.549 11.885 15.023 Purchase of R&D services in biotechnology (thousands of euros): Abroad 73.885 47.984 14.563 11.337 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 48 57 46 35 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 13 12 14 14 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 15 15 16 14 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 12 12 18 11 %Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets 16 18 21 9 %Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels 16 20 18 9 %Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception 16 17 18 11 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 36 40 43 26 %Companies that consider the following obstacles as very important considering biotechnology development : Time / cost 49 56 47 39 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 18 17 24 16 % Companies that have requested biotechnology patents 16 24 8 7 Number of patents requested 633 474 71 88 % Companies with income of an international origin related to biotechnological activities 24 32,7 15,5 15,2 % Turnover representing income of an international origin related to biotechnological activities 1,4 9 0,1 2,6 % Income of of an international origin related to biotechnological activities distributed in: Income received from the EU 57,3 35,5 37,3 77,6 % Income of of an international origin related to biotechnological activities distributed in: Income received from other countries 42,7 64,5 62,7 22,4 % Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services 82,3 91,3 80,2 74,3 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 16,5 7,1 . 25,6 % Income of an international origin related with activities according to the classification: Operating source abroad 1 1,1 19,6 0,1 % Income of an international origin related with activities according to the classification: Other 0,3 0,6 0,2 0 Notas: . '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute